Abstract:
Highly concentrated pharmaceutical wastewater has been pretreated by evaporation first to remove sulphur and inorganic salt thoroughly. Then a series of aerobic,anaerobic and anaerobic-aerobic treatment are carried out combinedly. The concentration of the COD of influent water changes from 2.8 ×104 mg/L to less than 300 mg/L because of the degradation of different microorganisms. After a 5 month stable running,the project was smoothly through the acceptance check fromZhengzhou Environmental Protection Bureau on January 12,2005.
Key words:
D-sodium ascorbate,
hydrolysis acidification,
biological treatment technology
摘要:
对高浓度制药废水首先进行浓缩蒸发预处理,彻底除硫除盐以后,再通过一系列的厌氧、兼氧、缺氧-好氧组合处理,充分发挥在不同环境条件下各类微生物代谢降解有机污染物的功能,使废水中COD由2.8×104mg/L降到300mg/L以下,经过5个月的稳定运行后,于2005年1月12日顺利通过郑州市环保局组织的达标验收。
关键词:
D-抗坏血酸钠,
水解酸化,
生物处理技术
CLC Number:
Pan Feng, Shi Lei, Wang Xuefeng, Ren Beilei, Cui Fengxia. Treatment for D-sodium ascorbate indus trial was tewater by combined biotechnology[J]. INDUSTRIAL WATER TREATMENT, 2007, 27(3): 75-77.
潘峰, 时蕾, 王学锋, 任蓓蕾, 崔凤霞. 组合生物技术处理D-抗坏血酸钠工业废水[J]. 工业水处理, 2007, 27(3): 75-77.